Asthma With Eosinophilic Phenotype Clinical Trials in Chengdu, Sichuan

A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma